Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Aegis Therapeutics seeks to out-license octreotide nasal spray

July 7, 2014

No Comments

VIB and Spain's CNIO partner for drug discovery

July 2, 2014

No Comments

Navitor Pharmaceuticals established to identify mTORC1 pathway drugs

June 23, 2014

No Comments

BIND Therapeutics partners with Roche on targeted nanopharmaceuticals

June 23, 2014

No Comments

MRC Technology sells melanocortin receptor program to Pfizer

June 20, 2014

No Comments

Horizon Discovery licenses CRISPR gene editing system

June 16, 2014

No Comments

Sentitive LSPR-based biosensor rapidly detects cancer biomarkers in serum

June 12, 2014

No Comments

Bristol-Myers Squibb and Syngene extend collaboration in India

June 6, 2014

No Comments

ImaginAb licenses PET imaging agents targeting murine T cells from UCLA

June 6, 2014

No Comments

ReGenX Biosciences and Voyager Therapeutics form NAV vector license agreement

June 5, 2014

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Drug design, drug delivery and technologies
RSS

Aegis Therapeutics seeks to out-license octreotide nasal spray

VIB and Spain's CNIO partner for drug discovery

Navitor Pharmaceuticals established to identify mTORC1 pathway drugs

BIND Therapeutics partners with Roche on targeted nanopharmaceuticals

MRC Technology sells melanocortin receptor program to Pfizer

Horizon Discovery licenses CRISPR gene editing system

Sentitive LSPR-based biosensor rapidly detects cancer biomarkers in serum

Bristol-Myers Squibb and Syngene extend collaboration in India

ImaginAb licenses PET imaging agents targeting murine T cells from UCLA

ReGenX Biosciences and Voyager Therapeutics form NAV vector license agreement

Today's news in brief

Today's news in brief

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

Proteomics study explores how protein changes influence disease

Abbvie and Simcere enter a $1B T-cell engager deal

Drug design, drug delivery and technologies RSS

Drug design, drug delivery and technologies
RSS